neurology

Neuroprotection in the early stages of Alzheimer’sNeuroprotection in the early stages of Alzheimer’s

Neuroprotection in the early stages of Alzheimer’s

A protein modification of the gene expression regulator MECP2 can convey neuroprotection under inflammation. Researchers at the University of Eastern…

Non-invasive brain cancer treatment targeting glioblastomaNon-invasive brain cancer treatment targeting glioblastoma

Non-invasive brain cancer treatment targeting glioblastoma

A non-invasive Brain Cancer Treatment has been announced by Ivy Brain Tumor Center, SonALAsense and Insightec: The First Patient Dosed…

Why bipolar patients don’t take their medsWhy bipolar patients don’t take their meds

Why bipolar patients don’t take their meds

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for…

Dementia: Time to implement research findingsDementia: Time to implement research findings

Dementia: Time to implement research findings

Dementia: Time to implement research findings: The last 20 years has seen significant advancements in our understanding of the human…

Mental health problems after concussionMental health problems after concussion

Mental health problems after concussion

A third of children and adolescents develop a mental health problem after a concussion, which could persist for several years…

Brain stimulation can treat severe OCDBrain stimulation can treat severe OCD

Brain stimulation can treat severe OCD

Australian-first clinical trial shows brain stimulation can treat severe OCD: Deep brain stimulation has been found to help people with…

Functional changes that regular coffee drinking has on the brainFunctional changes that regular coffee drinking has on the brain

Functional changes that regular coffee drinking has on the brain

A new study published in Molecular Psychiatry and sponsored by the Institute for Scientific Information on Coffee (ISIC), provides unique insights into the functional and…

First Patient in Historic First-in-Human Clinical Trial for GlioblastomaFirst Patient in Historic First-in-Human Clinical Trial for Glioblastoma

First Patient in Historic First-in-Human Clinical Trial for Glioblastoma

The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the…

‘What is autism?’‘What is autism?’

‘What is autism?’

Only 16% of autistic people and their families think the public understand autism in a meaningful way. We want to…

Cracking the ‘code’: spinal cord injuryCracking the ‘code’: spinal cord injury

Cracking the ‘code’: spinal cord injury

Cracking the 'code' to predict recovery for patients with spinal cord injury: Basic clinical information routinely collected as part of…

The toll of Schizophrenia and personality disordersThe toll of Schizophrenia and personality disorders

The toll of Schizophrenia and personality disorders

Schizophrenia and personality disorders are the most disabling mental health conditions to live with, according to scientists from The University of…

Bitesize Webinar: Dyslexia and Back to SchoolBitesize Webinar: Dyslexia and Back to School

Bitesize Webinar: Dyslexia and Back to School

Bitesize Webinar: Dyslexia and Back to School. The British Dyslexia Association (BDA) has been the voice of dyslexic people since…